[go: up one dir, main page]

NO932822L - 3-substituerte 1,2,3,4-oksatriazol-5-iminforbindelser, enfremgangsmaate for fremstilling derav og et farmasoeytisk preparat inneholdende angitte forbindelser - Google Patents

3-substituerte 1,2,3,4-oksatriazol-5-iminforbindelser, enfremgangsmaate for fremstilling derav og et farmasoeytisk preparat inneholdende angitte forbindelser

Info

Publication number
NO932822L
NO932822L NO93932822A NO932822A NO932822L NO 932822 L NO932822 L NO 932822L NO 93932822 A NO93932822 A NO 93932822A NO 932822 A NO932822 A NO 932822A NO 932822 L NO932822 L NO 932822L
Authority
NO
Norway
Prior art keywords
compounds
substituted
oxatatriazol
antified
imin
Prior art date
Application number
NO93932822A
Other languages
English (en)
Other versions
NO932822D0 (no
Inventor
Gunnar Leo Karup
Herbert Fritz Preikschat
Tim Niss Corell
Bodil Gyllembourg Lissau
Finn Priess Clausen
Soeren Bols Petersen
Boerge Ingvar Frisch Alhede
Original Assignee
Gea Farmaceutisk Fabrik As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea Farmaceutisk Fabrik As filed Critical Gea Farmaceutisk Fabrik As
Publication of NO932822L publication Critical patent/NO932822L/no
Publication of NO932822D0 publication Critical patent/NO932822D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Foreliggende oppfinnelse angår hittil ukjente 3-substituerte 1,2,3,4- oksatriazol-5-iminforbindelser som har vist seg å ha biologiske effekter som gjør dem egnet for behandling av kardiovaskulære sykdommer (blodklum- per), angina pectoris og astma, en fremgangsmåte for fremstilling derav og et farmasøytisk preparat omfattende angitte forbindelser.
NO932822A 1991-02-12 1993-08-09 3-substituerte 1,2,3,4-oksatriazol-5-iminforbindelser, enfremgangsmaate for fremstilling derav og et farmasoeytisk preparat inneholdende angitte forbindelser NO932822D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK023891A DK23891D0 (da) 1991-02-12 1991-02-12 3-substituerede 1,2,3,4-oxa-triazol-5-iminforbindelser og fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat indeholdende disse forbindelser
PCT/DK1992/000043 WO1992013847A1 (en) 1991-02-12 1992-02-11 3-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical preparation containing said compounds
JP4071309A JPH05286950A (ja) 1991-02-12 1992-03-27 ３−置換１，２，３，４−オキサトリアゾール−５−イミン化合物およびその製造方法

Publications (2)

Publication Number Publication Date
NO932822L true NO932822L (no) 1993-08-09
NO932822D0 NO932822D0 (no) 1993-08-09

Family

ID=26063591

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932822A NO932822D0 (no) 1991-02-12 1993-08-09 3-substituerte 1,2,3,4-oksatriazol-5-iminforbindelser, enfremgangsmaate for fremstilling derav og et farmasoeytisk preparat inneholdende angitte forbindelser

Country Status (23)

Country Link
US (1) US5405857A (no)
EP (1) EP0571485B1 (no)
JP (1) JPH05286950A (no)
AT (1) ATE111455T1 (no)
BG (1) BG97988A (no)
BR (1) BR9205624A (no)
CA (1) CA2100160A1 (no)
CZ (1) CZ163993A3 (no)
DE (1) DE69200412T2 (no)
DK (2) DK23891D0 (no)
ES (1) ES2062891T3 (no)
FI (1) FI933543A7 (no)
HU (1) HUT68643A (no)
IE (1) IE66384B1 (no)
LT (1) LT3184B (no)
LV (1) LV10617B (no)
NO (1) NO932822D0 (no)
PL (1) PL169685B1 (no)
PT (1) PT100121A (no)
RO (1) RO111190B1 (no)
SI (1) SI9210142A (no)
SK (1) SK78993A3 (no)
WO (1) WO1992013847A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4321109C2 (de) * 1993-06-25 1998-01-29 Sanol Arznei Schwarz Gmbh Pharmakologisch aktive Verbindungen mit Nitrosohydrazinpartialstruktur
AU8057194A (en) * 1994-10-07 1996-05-02 A/S Gea Farmaceutisk Fabrik Substituted 3-phenyl-1,2,3,4-oxatriazole-5-imines useful for the treatment of asthma and thrombosis
US8545950B2 (en) * 2004-04-02 2013-10-01 Curwood, Inc. Method for distributing a myoglobin-containing food product
US8741402B2 (en) * 2004-04-02 2014-06-03 Curwood, Inc. Webs with synergists that promote or preserve the desirable color of meat
US8053047B2 (en) 2004-04-02 2011-11-08 Curwood, Inc. Packaging method that causes and maintains the preferred red color of fresh meat
US8110259B2 (en) 2004-04-02 2012-02-07 Curwood, Inc. Packaging articles, films and methods that promote or preserve the desirable color of meat
US8029893B2 (en) 2004-04-02 2011-10-04 Curwood, Inc. Myoglobin blooming agent, films, packages and methods for packaging
US7867531B2 (en) 2005-04-04 2011-01-11 Curwood, Inc. Myoglobin blooming agent containing shrink films, packages and methods for packaging
US8470417B2 (en) 2004-04-02 2013-06-25 Curwood, Inc. Packaging inserts with myoglobin blooming agents, packages and methods for packaging
AU2010204723A1 (en) 2009-01-14 2011-08-18 The Salk Institute For Biological Studies Methods for screening and compounds that protect against amyloid diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2015878B (en) * 1978-03-10 1982-05-26 Shell Int Research Biocidal compositions
US4239355A (en) 1979-02-05 1980-12-16 Vought Corporation Visual simulator projection system
US4329355A (en) * 1979-03-01 1982-05-11 Henry David W Mesoionic antitumor compositions and methods for using the same in the treatment of cancer
JP2708500B2 (ja) 1988-09-27 1998-02-04 三菱電機株式会社 積層形燃料電池
JP2905041B2 (ja) * 1993-07-02 1999-06-14 三菱電機株式会社 メッセージ送受信装置
JPH0720904A (ja) * 1993-07-05 1995-01-24 Toshiba Corp プロセス制御装置のリミッタ設定装置
JP2009102700A (ja) 2007-10-24 2009-05-14 Sumitomo Kinzoku Kozan Siporex Kk 軽量気泡コンクリート補強鉄筋用防錆剤

Also Published As

Publication number Publication date
PL169685B1 (pl) 1996-08-30
BR9205624A (pt) 1994-11-08
US5405857A (en) 1995-04-11
SK78993A3 (en) 1994-03-09
ATE111455T1 (de) 1994-09-15
EP0571485A1 (en) 1993-12-01
FI933543L (fi) 1993-08-11
LV10617B (en) 1995-12-20
WO1992013847A1 (en) 1992-08-20
ES2062891T3 (es) 1994-12-16
CA2100160A1 (en) 1992-08-13
DK23891D0 (da) 1991-02-12
LT3184B (en) 1995-03-27
PT100121A (pt) 1993-05-31
LV10617A (lv) 1995-04-20
HU9302323D0 (en) 1993-10-28
IE66384B1 (en) 1995-12-27
DE69200412D1 (de) 1994-10-20
CZ163993A3 (en) 1994-01-19
IE920436A1 (en) 1992-08-12
EP0571485B1 (en) 1994-09-14
HUT68643A (en) 1995-07-28
NO932822D0 (no) 1993-08-09
BG97988A (bg) 1994-06-30
RO111190B1 (ro) 1996-07-30
JPH05286950A (ja) 1993-11-02
DE69200412T2 (de) 1995-02-16
FI933543A0 (fi) 1993-08-11
DK0571485T3 (da) 1994-10-17
FI933543A7 (fi) 1993-08-11
LTIP298A (en) 1994-08-25
SI9210142A (en) 1995-08-31

Similar Documents

Publication Publication Date Title
NZ233560A (en) 2,3-bis(1h-indole-3-yl)-maleinimide derivatives; pharmaceutical compositions and preparation thereof
CA2031714A1 (en) R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them
HUT51485A (en) Process for production of immune-hindering, monoquin, especially internuclein-1-hindering medical compositions
HUP9802762A2 (hu) Difenil-metilén-piperidin-származékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk
NO932822L (no) 3-substituerte 1,2,3,4-oksatriazol-5-iminforbindelser, enfremgangsmaate for fremstilling derav og et farmasoeytisk preparat inneholdende angitte forbindelser
FI894899A0 (fi) Menetelmä dispergoituvan kiinteän lääkeainekoostumuksen valmistamiseksi
DK0579996T3 (da) 5,10-Methylentetrahydrofolsyrecyclodextrin-inklusionsforbindelser
SE8505488D0 (sv) Isosilybinfri silibinin
DK1150963T3 (da) Substituerede 4-amino-2-aryltetrahydroquinazoliner, fremstilling og anvendelse deraf og farmaceutiske præparater indeholdende dem
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
DE59010302D1 (de) R-(-)-1-(5-Hydroxyhexyl)-3-methyl-7-propylxanthin, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
ATE218856T1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
NO905012L (no) Fremgangsmaate til fremstilling av cefemer, oksacefemer ogkarbacefemer og 3-sulfonyloksy-substituerte cefemer, oksacefemer og karbacefemer som utgangsprodukt ved fremgangsmaaten.
ATE243683T1 (de) Polyhydroxybutylpyrazinen, deren herstellung und diese enthaltende arzneimitteln
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
NO883219D0 (no) Framgangsmaate for framstilling av beta-lactam-forbindelse, mellomprodukt for framstilling av denne, og medisinske sammensetninger for behandling av bakteriologiske infeksjonssykdommer inneholdende denne.
HU896587D0 (en) 2-amino-carbonic acid derivatives, and medical preparations containing them as active agents, and process for the production of the active agents and the preparation
FR2654429B1 (fr) Nouveaux derives du methyl-2-propionate de 3,3,5-trimethylcyclohexanol, leur procede de preparation ainsi que compositions therapeutiques les contenant.
PT95757A (pt) Processo de preparacao de composicoes farmaceuticas a basede n-metil-2-(piridil-3)-tetra-hidrotiopirano-carbotioamida-2-oxido-1
ATE157670T1 (de) Digitoxigenin und dihydrodigitoxigenin 3-beta- derivate und pharmazeutische präparate davon, zur behandlung von hypertonie
NO993126L (no) Anvendelse av benzoylalkyl-1,2,3,6-tetrahydropyridiner
FR2637597B1 (fr) Nouveaux derives 17 soufres de la 20,21 dinoreburnamenine, leur procede de preparation et les intermediaires ainsi obtenus, leur application comme medicaments et les compositions pharmaceutiques les renfermant
ITMI911758A1 (it) Derivati della fisovenina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
DK311284D0 (da) 3-(4'-aminobutylamino)-propylamino-bleomycin-derivater, deres fremstilling og deres anvendelse som laegemidler
IT8619969A0 (it) Derivati del ferro, procedimento per la loro produzione e relative composizioni farmaceutiche